SiteMap
Alzheimer
Brain diseases
Research
Tau
APP
Abeta
VCDN group
flag

Aging

ALS

ALS/PDC Guam
AGD
Bri
CBD
DLDH
DM1
Down Syndrome
GSS
FTD
FTDP-17
Huntington
Hallenvorden
IBM
Lewy BD
MSA
NPiD c
Parkinson Dementia Guadeloupe
Parkinson
Dementia  in Parkinson 
Pick
Prion
PSP
PEP
Semantic  Dementia
SSP
  ToD

 

The amyloid cascade hypothesis (revisited):

Tau is upstream the amyloid cascade (Delacourte et al, 2002, Brain Aging, issue of June).

 

 

A: Neurofibrillary degeneration (NFD) corresponds to the intraneuronal accumulation of tau proteins into PHF (Paired Helical Filaments). PHF are composed of a triplet of abnormally phosphorylated Tau proteins, named "Tau 60, 64, 69" or PHF-Tau.

B: Tau pathology occurs frequently in aging brains, and specifically in the hippocampal region. Degenerating neurons die. Dead neurons are digested by glial cells (astrocytes and microglia).

C: Tau pathology precisely starts in the transentorhinal cortex and tends to spread in the entorhinal cortex and then in the hippocampus

D: APP dysfunction and/or Aß neurotoxicity (E) accelerate NFD so that it will spread in association cortical areas

F: The degenerating process progressively overcomes neuronal plasticity (repair, compensation), to provoke a progressive cognitive decline. 

Remarks:

APP DYSMETABOLISM AND AMYLOIDOSIS

D: Pathological mutations on APP, PS1, PS2 genes teach us that APP dysfunctions are directly linked to AD etiology. They provoke an aberrant catabolism, leading to an overproduction of Aß peptide, mostly 1-42 species. Aß peptides aggregate into amyloid plaques, under the influence of co-factors such as ApoE, complement, antiproteases, proteoglycan, etc. Amyloid plaques accumulate in the cortical grey matter.

In non-familial AD (99% of all cases), it is likely that there are also APP defects, since amyloid lesions are also observed, in similar quantities and distribution.

 

NEUROFIBRILLARY DEGENERATION

C: NFD invades the cortical areas along a precise, sequential, hierarchical pathway. Cognitive impairment is observed when the hippocampus, the temporal cortex as well as association brain areas are affected. 

The dynamic of NFD spreading is modulated by accelerating factors (inflammation, apoE E4, oxidative stress) ou neuroprotectants (estrogens, anti-oxidants, anti-inflammatory drugs, neurotrophic factors, ApoE E2, etc).

décembre 18, 2004
Home
Publications
flag
Research
Tau
APP
Abeta
Links 
ApoE
 
catenin
 
NSE
 
Parkin 
Pin1 
Presenilins,
Proteasome
Synuclein
 
 
Ubiquitin